The First Minister may be aware that the National Institute for Health and Care Excellence and the Scottish Medicines Consortium have

determined that cystic fibrosis drugs that are literally life saving will no longer be available on the national health service, because they consider the drugs to be clinically effective but not cost effective. It is important to say, though, that those already receiving Orkambi, Symkevi and Kaftrio will continue to do so, but new patients will not.

The First Minister knows that cystic fibrosis is a life-limiting condition. Will he meet CF families and work with the United Kingdom Government to negotiate a more acceptable cost from the drug manufacturer, Vertex, to literally save lives?